chrysoeriol (Flavocure Biotech)

N/A

Report date: 2025/03/14 16:38:14
NME

Base Information

Drug Namechrysoeriol (Flavocure Biotech)
Drug Alias NameCresorolFLT-3 inhibitor (Flavocure Biotech/University of Maryland Medical)chrysoeriol
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFlavocure Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Maryland Medical CenterFlavocure Biotech Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A